1 / 35

Gynecologic problems in Brest cancer

This article discusses gynecologic problems associated with breast cancer, including the clinical presentation and evaluation of tamoxifen, abnormal vaginal symptoms, post-menopausal bleeding, and the management of various gynecologic conditions. It also addresses the impact of pregnancy and sexual dysfunction in breast cancer patients, along with potential treatment options for hot flashes.

kstacy
Download Presentation

Gynecologic problems in Brest cancer

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Gynecologic problems in Brest cancer

  2. 1. drug 2.hot flash. 3.sexual dysfunction

  3. Tamoxifen:

  4. tamoxifen:

  5. CLINICAL PRESENTATION AND EVALUATION

  6. AUB: (ACOG) advised that women on tamoxifen should report any abnormal vaginal symptoms, including bloody discharge, spotting, staining, or leukorrhea

  7. Post menopausal bleeding:

  8. many women have cervical stenosis and office biopsy is not possible. In these patients, we manage expectantly if there is a thin endometrial echo (≤4 mm).

  9. PRE MENOPUASE:

  10. Endometrial Polyp:

  11. E endometrial polyp:

  12. Glandular Cystic Atrophic:

  13. Endometrial Hyperplasia:

  14. Endometrial cancer:

  15. ACOG:recommends against screening asymptomatic women on tamoxifen for EC

  16. Uterine sarcoma and carcinosarconma:

  17. If sarcoma is suspected, the patient should undergo surgical evaluation, we have a low threshold for hysterectomy when a large myometrial or endometrial mass is identified in a symptomatic woman on tamoxifen.

  18. Pregnancy and Brest cancer:

  19. Sexual dysfunction:

  20. Intrarosa: parstrone vaginal6.5 mg/dailyempty bladder

  21. Hot flash: HRT Not recommended

More Related